Recombinant human erythropoietin treatment protects the cardio-renal axis in a model of moderate chronic renal failure.
about
Restoration of Haemoglobin Level Using Hydrodynamic Gene Therapy with Erythropoietin Does Not Alleviate the Disease Progression in an Anaemic Mouse Model for TGFβ1-Induced Chronic Kidney Disease.Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat.Erythropoietin regulates immune/inflammatory reaction and improves neurological function outcomes in traumatic brain injury.
P2860
Recombinant human erythropoietin treatment protects the cardio-renal axis in a model of moderate chronic renal failure.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Recombinant human erythropoiet ...... oderate chronic renal failure.
@en
Recombinant human erythropoiet ...... oderate chronic renal failure.
@nl
type
label
Recombinant human erythropoiet ...... oderate chronic renal failure.
@en
Recombinant human erythropoiet ...... oderate chronic renal failure.
@nl
prefLabel
Recombinant human erythropoiet ...... oderate chronic renal failure.
@en
Recombinant human erythropoiet ...... oderate chronic renal failure.
@nl
P2093
P2860
P50
P1433
P1476
Recombinant human erythropoiet ...... moderate chronic renal failure
@en
P2093
Ana Margarida Teixeira
Frederico Teixeira
Paulo Santos
P2860
P304
P356
10.3109/0886022X.2010.509897
P50
P577
2010-01-01T00:00:00Z